&Partners’s DexCom DXCM Stock Holding History

&Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.32M	Buy	21,076 +6,598	+46%	+$459K	0.01%	1146
2025 Q4	$951K	Sell	14,478 -7,421	-34%	-$480K	0.01%	1245
2025 Q3	$1.46M	Buy	21,899 +149	+0.7%	+$11.8K	0.01%	908
2025 Q2	$1.88M	Sell	21,750 -1,170	-5%	-$91.7K	0.01%	698
2025 Q1	$1.56M	Buy	22,920 +8,142	+55%	+$664K	0.02%	638
2024 Q4	$1.2M	Buy	14,778 +2,859	+24%	+$212K	0.01%	692
2024 Q3	$797K	Buy	11,919 +2,402	+25%	+$197K	0.02%	658
2024 Q2	$1.08M	Buy	+9,517	New	+$1.2M	0.05%	328

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

&Partners's DXCM Position: Q1 2026 in Review

&Partners increased its DexCom (DXCM) stake by 46% in Q1 2026, buying an estimated $459K and bringing the position to 21,076 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #1146.

&Partners first reported a position in DXCM in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.88M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

&Partners held 21,076 shares of DexCom worth $1.32M as of Q1 2026.
&Partners bought 6,598 DexCom shares in Q1 2026, an estimated $459K.
DexCom made up 0.01% of &Partners's portfolio in Q1 2026, its #1146 holding.
&Partners first reported a position in DexCom in Q2 2024 and has held it in 8 quarters since.
&Partners's DexCom position peaked at $1.88M in Q2 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.